Stock market today: S&P 500 drops for fifth day as focus shifts to Powell’s speech
OVERLAND PARK, Kan. - SelectQuote, Inc. (NYSE:SLQT) reported fourth quarter fiscal 2025 results that exceeded analyst expectations on Thursday, with revenue rising 12.3% YoY to $345.1 million compared to the consensus estimate of $343.94 million. The company posted a quarterly loss of -$0.02 per share, significantly better than the analyst forecast of -$0.16 per share.
Shares of SelectQuote rose 1.09% in pre-market trading following the earnings release.
The healthcare services and insurance provider saw its consolidated revenue increase from $307.2 million in the same quarter last year, driven primarily by 47% growth in its Healthcare Services (NASDAQ:HCSG) segment, which generated $214 million in revenue. The company’s pharmacy business, SelectRx, reported a 31% increase in members to 108,018 compared to the prior year.
"The strength of our holistic healthcare services model was broadly exhibited in fiscal 2025, and we firmly believe the years ahead will increasingly drive substantial value for each of our stakeholders," said Tim Danker, SelectQuote Chief Executive Officer. "We are proud to have delivered financial results well in excess of our initial expectations for the 3rd consecutive year."
Looking ahead, SelectQuote provided an optimistic outlook for fiscal year 2026, projecting revenue between $1.65 billion and $1.75 billion, significantly above the analyst consensus of $1.52 billion. The midpoint of this guidance represents approximately 11.5% growth from fiscal 2025.
The company’s Senior segment saw a decline in the quarter, with revenue falling 28% YoY to $82.5 million and approved Medicare Advantage policies decreasing by 20% to 85,344. However, the Life segment showed improvement with revenue increasing 14% to $48 million.
SelectQuote finished the quarter with $35.7 million in cash and cash equivalents, down from $42.7 million at the end of fiscal 2024.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.